Obermatt
See Similar Stocks →

Greenwich Lifesciences

NAQ:GLSI · US3968791083
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book3
Dividend Yield—
Revenue Growth—
Profit Growth69
Capital Growth99
TSR 52w79
Leverage10
Liquidity89
Refinancing47
Combined—
Analyst Opinions100
Pro Holdings15
Opinion Changes50
Market Pulse55

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2006
Employees1
Websitegreenwichlifesciences.com
ISINUS3968791083
Last UpdateApr 2, 2026
Index & Theme
ImmunologyOncologyVaccinesBiopharmaBiotechnologyLife Science

Description

Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company. The company focuses on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy intended to prevent breast cancer recurrences. GP2 is a 9 am…

Similar Stocks

The companies this stock is ranked against.

Compare Greenwich Lifesciences with its peers
Savara
NSQ:SVRA
71
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Tango Therapeutics
NMQ:TNGX
16
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Cullinan Therapeutics
NSQ:CGEM
61
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Dianthus Therapeutics
NAQ:DNTH
20
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Syndax Pharmaceuticals
NSQ:SNDX
59
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Olema Pharmaceuticals
NSQ:OLMA
28
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →